Home > > North America And Global Lacrimal Device Market- Size, Share, Growth Rate, and Forecast
The North America Lacrimal Device market was valued at $60.8 Million in 2023, and is projected to reach $75.5 Million by 2030 growing at a CAGR of 3.18% from 2024 to 2030. Dry eye segment is expected to be the highest contributor to this market, with $24.7 Million in 2023, and is anticipated to reach $30.8 by 2030, registering a CAGR of 3.24%. Glaucoma segment is anticipated to reach $12.2 Million by 2030 with the highest CAGR of 3.37%. Dry eye and Glaucoma segments collectively expected to account for about 56.6% share of the North America Lacrimal Device market in 2023, with the former constituting around 40.6% share. Glaucoma and Drainage obstruction segments are expected to witness significant growth rates at a CAGR of 3.37% and 3.27% respectively, during the forecast period. Presently, share of these two segments is estimated to be around 31.4% in the overall North America Lacrimal Device market in 2023, and is anticipated to reach 31.7% by 2030. Application Dry eye Glaucoma Epiphora Drainage obstruction Lacrimal gland inflammation Other Applications Product Intubation sets Tubes Stents Cannula & spatula Dilator Punctal plugs Other Products End use Hospitals Ophthalmic clinics Diagnostic centers Other End uses BY REGION North America U.s. Canada Mexico Europe Germany France UK Italy Spain Russia Rest of Europe Asia China India Japan Australia South Korea Rest of Asia Middle East & Africa Brazil South Africa GCC Rest of MENA